• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Ivermectin as a treatment for Covid Long Haulers?

At a recent Senate hearing Dr.Pierre Kory gave powerful testimony into the efficacy of Ivermectin both as a prophylactic and as a treatment for the different stages of Covid-19.

Dr.Kory is an ICU specialist who has treated hundreds of Covid-19 patients. He is president of the Frontline Covid-19 Critical Care Alliance, whose members have had nearly 2,000 peer reviewed papers published between them.

The FLCCC doctors have developed the MATH+ Protocol, based on FDA approved medicines, to successfully treat Covid-19 patients. They have been using these repurposed medicines to achieve a 90% success rate for treating Covid-19 patients.

Launched in March the MATH+ Protocol consisted of:

Methylprednisolone and the antioxidant Ascorbic acid, which is given intravenously and in high doses. Both of these medicines have multiple synergistic physiologic effects and have been shown in multiple randomized controlled trials to improve survival in ARDS, particularly when given early in the disease. Thiamine is given to optimize cellular oxygen utilization and energy consumption, protecting the heart, brain, and immune system. Given the numerous clinical and scientific investigations that have demonstrated consistent, reproducible, and excessive levels of hyper-coagulation, particularly in the severely ill, the anticoagulant Heparin is used to both prevent and help in dissolving blood clots that appear with a very high frequency.''

Now the MATH+ Protocol has been updated to include Ivermectin for both prophylactic and clinical use.


In his Senate testimony Dr. Kory called on NIH to review the data in a recent paper that he and his colleagues have written, Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.


In their paper Kory et al comment on a new study that suggests Ivermectin can greatly benefit Covid Long Haulers.

Here is a quote from their paper on the use of Ivermectin as a treatment for Covid Long Haulers:

"Ivermectin in Post-COVID-19 Syndrome

Increasing reports of persistent, vexing, and even disabling symptoms after recovery from acute COVID-19 have been reported and which many have termed the condition as “long Covid” and patients as “long haulers”, estimated to occur in approximately 10% of cases (77–79). Generally considered as a post-viral syndrome consisting of a chronic and sometimes disabling constellation of symptoms which include, in order, fatigue, shortness of breath, joint pains and chest pain. Many patients describe their most disabling symptom as impaired memory and concentration, often with extreme fatigue, described as “brain fog”, and are highly suggestive of the condition myalgic encephalomyelitis/chronic fatigue syndrome, a condition well-reported to begin after viral infections, in particular with Epstein-Barr virus. Although no specific treatments have been identified for long COVID, a recent manuscript by Aguirre-Chang et al from the National University of San Marcos in Peru reported on the experience with ivermectin in such patients (80). They treated 33 patients who were between 4 and 12 weeks from the onset of symptoms with escalating doses of ivermectin; 0.2mg/kg for 2 days if mild, 0.4mg/kg for 2 days if moderate, with doses extended if symptoms Review of the Emerging Evidence Supporting the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
persisted. They found that in 87.9% of the patients, resolution of all symptoms was observed after two doses with an additional 7% reporting complete resolution after additional doses. Their experience suggests the need for controlled studies to better test efficacy in this vexing syndrome.''

Surely, this deserves greater publicity and action by public health authorities?


Senior Member
GUYS, what are current state-of-the-science long halters ivermectin protocol?
From this study:
They treated 33 patients who were between 4 and 12 weeks from the onset of symptoms with escalating doses of ivermectin; 0.2mg/kg for 2 days if mild, 0.4mg/kg for 2 days if moderate, with doses extended if symptoms persisted.

New long halters ivermectin study:
All of the above-mentioned patients received IVM, ranging from 12 up to 18 mg per os, on a weekly basis, until the symptoms disappeared, but no longer than 8 weeks
This new study goes with weekly dosing instead of daily dosing like the first quote does.

@bensmith I you started with 3mg daily and built up to higher dosage, correct? I decided to start with 3mg, and build up to 18mg, but not sure if it's better to go weekly or daily dosing.

edit: took 6mg more, feel better

We should check this page every month for new long covid ivermectin studies!
Last edited:


Senior Member
that pretty much sums it up. 3mg about a month in sometimes it feels like it helps a lot and other times not as much. Seems to help in waves.

id say its one if the stronger drugs ive taken.